Evidence map›Paper›PMID 33135346›Full record

ArticleClinical and translational medicine2020

TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K-AKT axis in colorectal cancer.

Peng Yang, Jie Li, Chaofan Peng, Yuqian Tan, Ranran Chen, Wen Peng, Qiou Gu, Jiahui Zhou, Lu Wang, Junwei Tang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Current medicinal chemistry · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. RNA polymerase I subunit D activated by Yin Yang 1 transcription promote cell proliferation and angiogenesis of colorectal cancer cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Peng YangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Jie LiThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Chaofan PengThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Yuqian TanThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Ranran ChenThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Wen PengThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Qiou GuThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Jiahui ZhouThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Lu WangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Junwei TangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Yifei FengThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Yueming SunThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

Jiangsu Key Medical Discipline ZDxKA2016005National Key R&D Program of China 2017YFC0908200)National Natural Science Foundation of China 81702338
6 · The paper itself

Abstract

backgroundLong noncoding RNAs (lncRNAs) have emerged as key regulators in multiple cancers, including colorectal cancer (CRC). However, the biological functions and molecular mechanisms underlying most lncRNAs in CRC remain largely unknown.

methodsA novel lncRNA (TCONS_00012883) was identified using RNA sequencing. The level of TCONS_00012883 expression in CRC was analyzed by qRT-PCR. The biological functions of TCONS_00012883 in CRC were investigated by a series of in vitro and in vivo experiments: CCK8, colony formation, EdU, flow cytometric assays, transwell assays, and mouse xenograft. The molecular mechanisms of TCONS_00012883 were demonstrated by RNA pulldown, mass spectrometry analysis, RIP, coimmunoprecipitation, RNA sequencing, chromatin immunoprecipitation, and rescue experiments.

resultsElevated expression of TCONS_00012883 was confirmed in CRC and positively associated with a poor prognosis. Functionally, gain- and loss-of-function assays indicated that TCONS_00012883 promoted proliferation and metastasis of CRC cell lines in vitro and in vivo. Mechanistically, RNA pulldown and mass spectrometry analysis showed that DEAD-box helicase 3 (DDX3) was the protein partner of TCONS_00012883. Furthermore, RNA sequencing assay revealed that matrix metallopeptidase 1 (MMP1) was the downstream of TCONS_00012883. Intriguingly, we found that transcription factor (YY1) could serve as a bridge between TCONS_00012883, DDX3, and MMP1.

conclusionsTCONS_00012883 significantly promoted CRC progression via the DDX3/YY1/MMP1 axis, and thus, may act as a major role in diagnosis and therapy of CRC.

Indexed as

colorectal cancerDDX3MMP1TCONS_00012883YY1

Identifiers

PMID33135346
PMCPMC7568852
OpenAlexW3093903931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.